Short Communication Volume 12 Issue 1
School of Life Sciences, Shanghai University, PR China
Correspondence: Da-Yong Lu, School of Life Sciences, Shanghai University, PR China
Received: May 16, 2025 | Published: June 5, 2025
Citation: Da-Yong L, Hong-Ying w. Pulmonary nodules, knowledge renovation and comprehensive studies. J Lung Pulm Respir Res. 2025;12(1):18-19. DOI: 10.15406/jlprr.2025.12.00326
Technical advance and popularity of computerized tomography discovers a lot of pulmonary nodules in many adult people. Due to new discovery, there is no well-formed therapeutics that can cover all human beings. There are many therapeutic options and debates for properly handling this phenomenon with scientific knowledge and techniques supporting. However, as a new discovered event, the therapeutic options are lagged behind and riskly to patients requiring therapies. Previously, we discussed this event theoretically and emerging technology. This article addresses this problem for future noticing and therapeutic breakthroughs.
Keywords: Pulmonary nodules, drug treatment, disease diagnosis, surgery
The popularity and healthcare checking of computerized tomography discovers dilemma phenomenon—wide spread of pulmonary nodules in a lot of healthy and asymptomatic adults.1 Due to new discovery, there is no well-formed therapeutics that can cover all human beings. There are many therapeutic options and debates after this discovery. The potential threat and uncertainty for human health problems by analysing progression and characteristics of pulmonary nodules and different pathogenesis in image and biomarkers is an emerging challenge welcoming new therapeutic paradigms. Knowledge exchanges and therapeutic breakthroughs (advanced diagnosis and personalized medicine) for that is needed.
No good way of disease therapeutics can be made without clearly understanding its pathogenesis and pharmacology. As a first impression, cancer cannot be attributed for all patients. Surgical indication and procedure optimization should be studied and analysed for knowledge advances, patient survival increases and cost reduction.2 Several approaches should be underway for therapeutic improvements;
Major topics
Current norm of surgical procedure cannot be the priority for many human beings. At present knowledge, many pulmonary nodules in human lung might not be all fatal. Pulmonary nodules are not associated with malignancy in 100% rates. It also needs to find and determination of the origin of nodular tumours (primary or metastasis). Respiratory system infection, blood coagulation, and many underlying diseases (cardio vasculature and overweight) might be disease origin or complication to surgery. Anticancer drugs,3 traditional medicine,4-7 viral infections8 and drug evaluative systems9 and therapeutics to different individuals may be useful.10,11 These kinds of therapeutic or surgery studies should be specified.
The different pathogenesis pathways and approaches are associated to;
This manuscript is a full initiative of the author and does not have any funding.
The author states that he has no conflict of interest.
©2025 Da-Yong, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.
November is observed as Lung Cancer Awareness Month, dedicated to raising
awareness, encouraging early detection, and supporting advances in lung cancer prevention, diagnosis, and treatment.
Researchers and healthcare professionals play an important role in this effort by promoting evidence-based practices
and improving patient care and outcomes.
In recognition of this initiative, the Journal of Lung, Pulmonary and Respiratory Research (JLPRR) is offering a 40%
reduction in the Article Processing Charge (APC) for manuscripts received on or before November 30, 2026
.